Work

Patterns of durable response with intralesional talimogene laherparepvec (T-VEC): Results from a phase III trial in patients with stage IIIb-IV melanoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.9026

Authors: Merrick I. Ross, Robert Hans Ingemar Andtbacka, Igor Puzanov, Mohammed M. Milhem, Frances A. Collichio, Keith A. Delman, R Dirk Noyes, Jonathan S. Zager, Lee D. Cranmer, Lynn E. Spitler, Eddy C. Hsueh, David W. Ollila, Thomas Amatruda, Lisa Chen, Jennifer L. Gansert, Howard L Kaufman

Institutions: The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Iowa Hospitals and Clinics, University of North Carolina at Chapel Hill, Emory University, University of Utah, Moffitt Cancer Center, University of Arizona Cancer Center, Northern California Melanoma Center, Saint Louis University, Minnesota Oncology, Amgen (United States), Rutgers Cancer Institute

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2593971888

Cites:

Cited by: 6

Related to: 10